| Dr Mark A Oatman, MD | |
|
154 S Mccord Rd, Ponca City, OK 74604-5885 | |
| (580) 747-9039 | |
| Not Available |
| Full Name | Dr Mark A Oatman |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 154 S Mccord Rd, Ponca City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205814449 | NPI | - | NPPES |
| 200127510A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04-29587 (Kansas) | Secondary |
| 207Q00000X | Family Medicine | 26016 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Century Hospice Of Tulsa | Tulsa, OK | Hospice |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Precision Pain Management Llc | 8628390515 | 4 |
| Triad Health Systems Llc | 1355763160 | 7 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
| Entity Name | Internal Medicine Associates Of Ponca City Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811073158 PECOS PAC ID: 9931174463 Enrollment ID: O20040830000069 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
| Entity Name | Precision Pain Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841692274 PECOS PAC ID: 8628390515 Enrollment ID: O20141203002266 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
| Entity Name | Triad Health Systems Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245867258 PECOS PAC ID: 1355763160 Enrollment ID: O20200624002858 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
| Entity Name | Triad Ltc Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477290591 PECOS PAC ID: 2668856477 Enrollment ID: O20220829000473 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Oatman, MD 154 S Mccord Rd, Ponca City, OK 74604-5885 Ph: (580) 747-9039 | Dr Mark A Oatman, MD 154 S Mccord Rd, Ponca City, OK 74604-5885 Ph: (580) 747-9039 |
News Archive
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company has completed patient enrollment of its Phase 2 study with an experimental oral parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Early use of available heart failure drugs slows the progressive decline in heart function before symptoms are apparent in boys and young men with Duchenne muscular dystrophy (DMD), according to a new study published online by The Lancet Neurology.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.
Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.
› Verified 7 days ago
Karen S Adams, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 421 E Hartford Ave, Ponca City, OK 74601 Phone: 580-762-3342 Fax: 580-762-5841 | |
Monica Dawn Leach, NP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 200 White Eagle Dr, Ponca City, OK 74601 Phone: 580-765-2501 | |
Mark Edward Rigney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 Fairview Ave Ste 1, Ponca City, OK 74601 Phone: 580-765-6647 Fax: 580-765-6699 | |
Bienvenido Dena Paz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 White Eagle Dr, Ponca City, OK 74601 Phone: 580-765-2501 Fax: 580-765-7289 | |
Dr. Brad Alan Liston, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1908 N 14th St Ste 204, Ponca City, OK 74601 Phone: 580-763-5900 Fax: 580-763-5901 | |
Aaron Paul Wilcox, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 Fairview Ave Ste 201, Ponca City, OK 74601 Phone: 580-762-9355 Fax: 580-762-3420 |